Withus Pharmaceutical Co Ltd (330350)

Currency in KRW
7,390
-60(-0.81%)
Closed·
330350 Scorecard
Full Analysis
Impressive gross profit margins
330350 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7,3707,470
52 wk Range
5,61010,450
Key Statistics
Bid/Ask
7,390.00 / 7,410.00
Prev. Close
7,450
Open
7,380
Day's Range
7,370-7,470
52 wk Range
5,610-10,450
Volume
15.14K
Average Volume (3m)
777.2K
1-Year Change
-12.65%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
330350 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Withus Pharmaceutical Co Ltd Company Profile

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name to WITHUS PHARMACEUTICAL Co.,LTD. in October 2007. WITHUS PHARMACEUTICAL Co.,LTD. was founded in 2004 and is headquartered in Seoul, South Korea.

Employees
121

Compare 330350 to Peers and Sector

Metrics to compare
330350
Peers
Sector
Relationship
P/E Ratio
22.1x5.7x−0.5x
PEG Ratio
−0.420.020.00
Price/Book
1.0x0.7x2.6x
Price / LTM Sales
1.0x0.8x3.3x
Upside (Analyst Target)
-28.6%43.4%
Fair Value Upside
Unlock19.8%7.1%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
125.00 / --
Revenue / Forecast
25.77B / --
EPS Revisions
Last 90 days

330350 Income Statement

FAQ

What Stock Exchange Does Withus Pharma Trade On?

Withus Pharma is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Withus Pharma?

The stock symbol for Withus Pharma is "330350."

What Is the Withus Pharma Market Cap?

As of today, Withus Pharma market cap is 97.56B.

What Is Withus Pharma's Earnings Per Share (TTM)?

The Withus Pharma EPS (TTM) is 334.25.

From a Technical Analysis Perspective, Is 330350 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Withus Pharma Stock Split?

Withus Pharma has split 1 times.

How Many Employees Does Withus Pharma Have?

Withus Pharma has 121 employees.

What is the current trading status of Withus Pharma (330350)?

As of 10 Aug 2025, Withus Pharma (330350) is trading at a price of 7,390.00, with a previous close of 7,450.00. The stock has fluctuated within a day range of 7,370.00 to 7,470.00, while its 52-week range spans from 5,610.00 to 10,450.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.